Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No price history available for this symbol yet.
No one on the platform currently holds NGEN.V.
No tracked institution reports a position in NGEN.V as of their last filing.
No one on the platform has traded NGEN.V yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $0 | — | $-0.39 | $-0.39–$-0.39 | — | 2 |
| 2027 | $0 | — | $-0.43 | $-0.50–$-0.36 | — | 2 |
| 2028 | $213M | — | $1.16 | $0.02–$2.31 | — | 2 |
| 2029 | $678M | +218.1% | $4.77 | $4.77–$4.77 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-05-13 | $-0.09 | $-0.37 | -321.8% |
| 2025-11-25 | $-0.06 | $-0.06 | +5.3% |
| 2025-08-27 | $-0.06 | $-0.13 | -110.9% |
| 2025-05-14 | $-0.09 | $-0.06 | +33.3% |
| 2025-04-03 | $-0.08 | $-0.13 | -62.5% |
| 2024-11-14 | $-0.09 | $-0.07 | +22.2% |
| 2024-08-22 | $-0.09 | $-0.11 | -22.2% |
| 2024-04-23 | $-0.09 |
| $-0.04 |
| +57.6% |
| +3.03% |
| $591M |
| — |
| HBP.TOHelix BioPharma Corp. | $1.80 | +5.88% | $137M | — |
| HLS.TOHLS Therapeutics Inc. | $3.87 | -2.76% | $121M | — |
Source: Financial Modeling Prep · peers by sector/industry